UCHL1 and cancer: In summary, our study elucidated a novel molecularly-defined subgroup of UCHL1-related cancers across solid tumor entities, which is characterized by a higher genomic instability and increased sensitivity to radiotherapy or genotoxic agents as potential treatment vulnerabilities.